Literature DB >> 1346069

Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.

M Le Guern1, J A Levy.   

Abstract

In studies on viral interference, cloned T-cell lines chronically infected with human immunodeficiency virus (HIV) type 1 or HIV-2 were inoculated with several strains of these two AIDS retrovirus subtypes. HIV-2UC1-infected cells, which still express the CD4 receptor, could be superinfected with a variety of HIV-1 and HIV-2 strains. This event was accompanied by cytopathic effects in the cells and production of pseudotype virions with an expanded cellular host range. HIV-1- or HIV-2-infected clonal cell lines, which did not express CD4, could not be superinfected by any HIV strains but were coinfected after transfection of molecular clones into the persistently infected cells. These observations indicate that viral interference with HIV occurs at the cell surface and involves a down-modulation of the CD4 molecule. If the CD4 protein is expressed, superinfection can take place, and phenotypically mixed virus particles are produced. Since HIV-1 and HIV-2 dually infected individuals have been detected, these in vitro observations may have relevance to the in vivo state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346069      PMCID: PMC48237          DOI: 10.1073/pnas.89.1.363

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells.

Authors:  S B Tang; J A Levy
Journal:  J Virol Methods       Date:  1991-06       Impact factor: 2.014

2.  A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

3.  Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient.

Authors:  L A Evans; J Moreau; K Odehouri; D Seto; G Thomson-Honnebier; H Legg; A Barboza; C Cheng-Mayer; J A Levy
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

4.  Differential ability of human immunodeficiency virus isolates to productively infect human cells.

Authors:  L A Evans; T M McHugh; D P Stites; J A Levy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

5.  Observations on the envelope properties of RSV(O).

Authors:  R Ishizaki; T Shimizu
Journal:  Virology       Date:  1970-02       Impact factor: 3.616

6.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Human immunodeficiency virus can productively infect cultured human glial cells.

Authors:  C Cheng-Mayer; J T Rutka; M L Rosenblum; T McHugh; D P Stites; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M Tersmette; R E de Goede; B J Al; I N Winkel; R A Gruters; H T Cuypers; H G Huisman; F Miedema
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome.

Authors:  J A Levy; L H Tobler; T M McHugh; C H Casavant; D P Stites
Journal:  Clin Immunol Immunopathol       Date:  1985-06

10.  High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.

Authors:  L S Kaminsky; T McHugh; D Stites; P Volberding; G Henle; W Henle; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

View more
  22 in total

1.  Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.

Authors:  John T West; Sally K Weldon; Stephanie Wyss; Xiaoxu Lin; Qin Yu; Markus Thali; Eric Hunter
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.

Authors:  Miranda Harris; Sneha Ratnapriya; Angela Chov; Héctor Cervera; Alisha Block; Christopher Gu; Nathaniel Talledge; Louis M Mansky; Joseph Sodroski; Alon Herschhorn
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

4.  Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix.

Authors:  Ajay K Bhatia; Nancy Campbell; Antonito Panganiban; Lee Ratner
Journal:  Virology       Date:  2007-08-13       Impact factor: 3.616

5.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo.

Authors:  P D Yin; W S Hu
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 7.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

8.  Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.

Authors:  Kathie-Anne Walters; Michael A Joyce; William R Addison; Karl P Fischer; D Lorne J Tyrrell
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4.

Authors:  D J Volsky; M Simm; M Shahabuddin; G Li; W Chao; M J Potash
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.

Authors:  Ajay K Bhatia; Rajnish Kaushik; Nancy A Campbell; Suzanne E Pontow; Lee Ratner
Journal:  Virology       Date:  2008-12-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.